Comparison of high energy radial extra corporeal shock wave therapy with local corticosteroid injection in the treatment of plantar fasciitis.

Effectiveness of high energy radial extra corporeal shock wave therapy (ESWT) versus local corticosteroid injection in the treatment of chronic plantar fasciitis, a single blinded randomized clinical trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201306163217N7

Enrollment

Registered

2014-03-04

Start date

2013-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic plantar fascitis. Fibroblastic disorder, plantar fascial fibromatosis, plantar fasciitis.

Interventions

Intervention 1: Radial extracorporeal shock wave.Using high energy radial shock wave with energy flux intensity of 0.25mj/mm2 , 2000 impulse (4Bar ) and frequency of 10 HZ twice a week for five s

Treatment - Devices

Treatment - Drugs

Radial extracorporeal shock wave.Using high energy radial shock wave with energy flux intensity of 0.25mj/mm2 , 2000 impulse (4Bar ) and frequency of 10 HZ twice a week for five sessions.

One local injection of 40 mg triamcinolone in tender point of medial zone of heel. (Amp triamhexal. made by Germany)

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all of patients with chronic plantar fasciitis and heel pain and local tenderness for more than 2 months. Exclusion criteria: 1) History of systemic inflammatory diseases. 2) Infective or malignant diseases. 3) History of direct trauma with or without foot bones fracture. 4) Previous physiotherapy in the past 3 months or local steroid injection in the past 6 months. 5) Active S1 radiculopathy (which could be justify the cause of plantar fascia pain). 6) Heel pain related to Achilles bursitis. 7) Presence of myofascial pain syndrome and trigger points in gastrocnemius muscle.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: Before treatment and 4 & 8 weeks after treatment. Method of measurement: Visual Analogue Scale with 0-100mm grading.;Daily foot functional ability. Timepoint: Before treatment and 4 & 8 weeks after treatment. Method of measurement: Questionnaire of foot function index.;Satisfaction rate. Timepoint: at the end of intervention. Method of measurement: satisfaction rating scale in according 4 grades:Excellent, good, moderate and poor.	—

Measure

Time frame

Pain intensity. Timepoint: Before treatment and 4 & 8 weeks after treatment. Method of measurement: Visual Analogue Scale with 0-100mm grading.;Daily foot functional ability. Timepoint: Before treatment and 4 & 8 weeks after treatment. Method of measurement: Questionnaire of foot function index.;Satisfaction rate. Timepoint: at the end of intervention. Method of measurement: satisfaction rating scale in according 4 grades:Excellent, good, moderate and poor.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaraz Notghi

Tabriz university of medical science

faraz.notghi@yahoo.com+98 41 1337 3967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026